Vivani Medical Inc. (VANI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $91.11M
Last updated: Nov 17, 2026 at 11:03 AM ET
Vivani Medical Inc. (VANI) Stock Forecast
Analysts expect Vivani Medical (VANI) to earn -$0.32 per share in the fiscal year ending Dec 31, 2026. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 2 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$0.32
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.39
- EPS consensus
- Next report
- Mar 24, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.32 | -$0.33 to -$0.31 | 2 |
| Dec 31, 2027 | -$0.39 | -$0.54 to -$0.27 | 3 |
Quarterly Estimates
The EPS consensus rises from -$0.08 for the quarter ending Dec 31, 2026 to -$0.07 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.08 | -$0.09 to -$0.07 | 5 |
| Mar 31, 2027 | -$0.07 | -$0.07 to -$0.07 | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.35.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.32 | -$0.33 | -$0.33 | -$0.33 | -$0.35 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.39 | -$0.39 | -$0.39 | -$0.39 | -$0.40 | N/A |
Frequently Asked Questions About VANI
What is the VANI stock forecast?
Consensus analyst estimates put Vivani Medical's EPS at -$0.32 for the fiscal year ending Dec 31, 2026. The consensus rating from 3 analysts is Buy.
How do analysts rate VANI stock?
Of 3 analysts covering Vivani Medical, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from VANI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.32, with estimates from -$0.33 to -$0.31 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.39, with estimates from -$0.54 to -$0.27 from 3 analysts.
How many analysts cover VANI?
3 analysts rate Vivani Medical stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
VANI pages: Overview, Earnings, Forecast, Financials, Competitors